Press Release
TGaS® Advisors Named to Philadelphia 100®, Region’s Fastest Growing Privately Held Companies
East Norriton, Penn., October 7, 2009 – TGaS Advisors, a leading benchmark and advisory services firm for pharmaceutical commercial organizations, announced it has been included on the Philadelphia 100’s 2009 list of the fastest growing privately held companies in the Philadelphia region for the second year in a row. The Philadelphia 100 is an annual program conducted by the Entrepreneurs’ Forum of Greater Philadelphia, Philadelphia Business Journal and Wharton Small Business Development Center. Rankings were unveiled at the program’s 20th anniversary event held October 1, 2009, at Philadelphia’s Annenberg Center for the Performing Arts.
Managing Partner Stephen E. Gerard attributes TGaS Advisors’ growth to the firm’s collaborative relationship with clients and innovative thinking about their needs. “As the healthcare industry undergoes radical change, leaders of Commercial Organizations have a unparalleled opportunity to provide valuable guidance to their companies,” said Gerard. “As trusted advisors to our clients, we can give them the objective advice they need to be more strategic and more effective.”
Despite the difficult economic climate, TGaS Advisors achieved a three-year growth rate of more than 500 percent, introducing new benchmarks in Commercial Compliance, Integration Services and Sales Leadership, adding to its client roster and providing deeper services to existing clients. The company has added staff, including the recent appointment of Anthony Sorce as Vice President for New Business Development.
According to Gerard, the firm’s achievements arise from TGaS Advisors’ unique concept of working from the “outside-in,” creating a community of Operations executives and providing confidential fact-based answers to the question, “How do other pharmaceutical companies do ‘it’?”® Most TGaS Advisors associates are 20-year industry veterans, coming to the firm from such companies as Wyeth, Roche Pharmaceuticals, Schering-Plough, King Pharmaceuticals, Abbott Laboratories, Yamanouchi (Astellas), Thomson Reuters, IMS Health and SimStar (now Rosetta Interactive). Earlier this year, TGaS Advisors was named to the Inc. 500/5000 list of the fastest-growing private companies in the United States, ranking first in Business Products & Services and 11th overall in the Mid-Atlantic region (PA-NJ-DE-MD). The company also placed in the top 50 nationwide for Business Products & Services.
About TGaS® Advisors
TGaS Advisors, ranked in the top 50 among U.S. Business Products & Services companies by the Inc. 500, is the leader in benchmarking and advisory services to the pharmaceutical and biopharmaceutical industry. The TGaS Advisors roster includes nine of the top 10 and the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm’s benchmarking and advisory services suite of solutions, PharmaStance®, provides clients with a way to measure where they stand with respect to their organizations and answers the question, “How do other pharmaceutical companies do ‘it’?”® TGaS Advisors is based in East Norriton, Pennsylvania.
MEDIA CONTACT: Susan Youdovin, susan@rosica.com, 201.843.5600
- Other 2009:
- TGaS Advisors’ Gerard Featured on Executive Leaders Radio
- TGaS Advisors Hosts Pharma Commercial Operations Summit on 2010 Trends
- TGaS Advisors’ Donna Wray Invited to Present Benchmark Findings and Recommendations on Digital Marketing Issues at DDMAC Hearings
- The Right Skill Sets for Pharma More Critical Than Ever in 2009, According to TGaS Advisors Organizational Career Guide
- TGaS Advisors Sample Accountability Benchmark Shows Stepped-Up Focus on Compliance Operations
- Brian Deppen Joins TGaS Advisors Managed Markets Practice
- Managed Markets Leaders Identify Most Urgent Concerns
- TGaS Advisors Appoints Anthony Sorce, Vice President, New Business Development and Jeff Wojcik Promoted to Principal
- TGaS Advisors Named to 2009 INC 500/5000, Ranked First in Business Products & Services in the Mid-Atlantic Region
- Commercial Compliance Benchmark Charts Promotional Monitoring by Pharmaceutical Companies
- Critical Job Skills, Career Progression are Key Issues for Sales Ops Leadership
- Taking “Closed Loop” to the Next Level: Re-Imagining Sales and Managed Markets as an Interactive System
- TGaS Advisors Convenes “Mega-Summit” for Pharma Leaders on the Impact of Industry Trends on Commercial Organizations
- FDA Letters Hobble a Favorite Relationship Marketing Tactic of TGaS Advisors Benchmark Companies Page
- TGaS Advisors Analytics Experts Urge Pharma Management Sciences Professionals to Help Shape Industry Future
- TGaS Advisors Appoints Curt Staab Director, Management Advisor, Sales Advisory Practice
- TGaS Advisors Offers Benchmark-based Services to Support Integration Following Recent Wave of Mergers & Acquisitions
- TGaS Advisors Introduces Commercial Compliance Benchmark